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ABSTRACT 
The use of plant products in the management of diabetes has gained ground in pharmacotherapy. It becomes imperative to evaluate 
the antidiabetic effects of fruit extracts of Ziziphus mauritiana (HMZM), Ziziphus spina christi (HMZS) and Glibenclamide on blood 
glucose, total protein, albumin and lipid profile in alloxan induced diabetic rats. 68 albino rats weighing 70 - 130g were used in this 
study. 26 rats were used for acute toxicities of Ziziphus mauritiana and Ziziphus spina christi. 42 rats of 7 groups of 6 rats each were 
used to test antidiabetic effects of Ziziphus mauritiana and Ziziphus spina christi plant extracts. Group 1 served as the negative 
control, groups 2-7 were intraperitoneally administered 360mg/kg of alloxan in normal saline respectively. Group 2 served as 
positive control, groups 3 and 4; 5 and 6 were respectively administered daily dose of 200 and 400mg/kg of HMZM and HMZS, 
group 7 was administered 0.21mg/kg of glibenclamide. Results showed Ziziphus mauritiana and Ziziphus spina christi non toxic at 
dose of 5000mg/kg. 48 hours after alloxan administration, blood glucose levels were found to be significantly higher (P<0.05) in 
groups 2-7 compared to group 1, thus confirming induction of diabetes. In groups 3-7, on 7th and 14th days of administration of 
extracts and Glibenclamide, there was a significantly lower (p<0.05) serum glucose, triacylglycerol, High density Lipoprotein, Low 
density lipoprotein and significantly higher (P > 0.05) serum level of total protein and albumin compared to group 2. The results 
obtained showed a significantly lower (P < 0.05) serum level of glucose. The effects of HMZM and HMZS fruit extracts on blood 
glucose, total protein, albumin and lipid profile was dose dependent. Conclusively, this study has demonstrated the antidiabetic 
effects of HMZM and HMZS with HMZS having a more pronounced effect on Blood glucose and lipid profile. 
Keywords: Antidiabetic, Blood glucose, lipid profile, Glibenclamide, Ziziphus mauritiana, Ziziphus spina Christi. 
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INTRODUCTION 
Diabetes may be defined as a group of diseases resulting 
from insufficient or no insulin production or the 
combination of both
1
. Diabetes mellitus as a disease is 
ranked the 7th killer disease in the world
2
. The 
International Diabetes Federation stated that about 366 
million people are living with diabetes and this figure is 
projected to increase to 552 million by the year 2030
3
. 
4
 
stated that according to WHO, the number of diabetic 
patients estimated would increase to at least 300 million 
by 2025. The important regulatory role of insulin on 
glucose and lipid metabolism cannot be over 
emphasized. Thus, defect in hormonal insulin production 
is not unconnected to the unset of diabetes mellitus, 
which is associated with pronounced abnormality of 
lipoprotein metabolism, leading to hyperlipidaemia. 
Altered lipoprotein metabolism may be as a result of 
increase in production, decreased in absorption and 
maybe when the composition of lipoproteins changed, 
which in turn result in hyperlipaedemia in diabetes
5
. 
According to Clinical Practice Guidelines Expert 
Committee 2013, individuals who have history of or are 
suffering from certain diseases, such as genetic 
syndrome e.g. down syndrome, turner syndrome etc, 
pancreatic diseases e.g. cancer, cystic fibrosis, 
pancreatitis etc, Viral infections e.g cytomegalovirus etc, 
and endocrine diseases e.g. acromegaly, hyperthyroid 
etc, are likely to have diabetes. Diabetes may also result 
from the use of certain drugs such as thiazides, used to 
treat high blood pressure, Glucocorticoids drugs, such as 
cortisone, statins, used to treat high cholesterol level, 
drugs used to treat certain mental problems and 
epilepsy
6
. Experts have classified diabetes into three 
major types, which include type1, insulin deficiency, 
type 2, insulin resistance and gestational diabetes results 
from insulin blocking hormone during pregnancy. Other 
forms of diabetes include; Maturity Onset Diabetes of 
the Young (MODY), a rare form of diabetes that 
generally occurs before the age of 25 in individuals of 
normal weight and Latent Autoimmune Diabetes of 
Adults (LADA), which occurs in adults between 30 to 
50 years where there is a rapid dependence on insulin 
due to the slow and progressive destruction of the beta 
cells of the pancreas by the presence of antibodies
7
. 
General symtoms of diabetes include; slow healing 
wounds, fatigue, blurry vision, excessive thirst and 
hunger, frequent urination and itchy and scaly skin
1
. 
Hyperlipidaemia has been found to be associated with 
the alteration of lipid and lipoproteins metabolism in the 
onset of diabetes mellitus
5
. Several researches have 
reported the positive correlation of metabolic disorders 
in lipid and lipoproteins metabolism in individuals 
suffering from diabetes to arteriosclerosis
8
.  Several 
factors are said to be likely responsible for diabetic 
dyslipidemia, which include; insulin effects on liver 
apoprotein production, regulation of lipoprotein lipase 
(LpL), actions of cholesteryl ester transfer protein 
(CETP) and peripheral actions of insulin on adipose and 
muscle
9
. Another report reveals that individuals 
diabetics with cardiovascular heart disease, were shown 
to have high total cholesterol, high low density 
lipoprotein (LDL) and reduced high density lipoprotein 
(HDL) compared to those without cardiovascular 
disease
10
. Hypertriacylglycerolemia, reduced HDL and 
ketoacidosis have been reported to found in poorly 
controlled type1 diabetes
11
.  
Hyperglycemia, a metabolic challenge is connected to 
insulin deficiency in type-1 diabetes and insulin 
resistance in type 2 diabetes. 
12
 report that 
Hyperglycemia and hyperlipidemia blocks the Insulin-
Inositol polyphosphate-5-phosphatase (Inpp5f) negative 
feedback loop and increase of Inpp5f in diabetes due to 
hyperglycemia and hyperlipidemia plays an important 
role in diabetic cardiomyopathy suggest that, increase of 
Inpp5f might be one of the key mediators of metabolic 
stress (hyperglycemia and hyperlipidemia), which is an 
induced insulin signaling deficiency. 
Several researchers have reported volumes of work 
showing how plants and fruits have provided useful 
remedies as hypoglycemic and hypolipidemic agents 
owing to the presence of phytochemical and bioactive 
compounds in plants and fruits. 
13
 reported the 
hypoglycemic and lipid lowering effects of aqueous 
fresh Leaf extract of Chromolaena odorata (linn) in 
albino wistar rats fed different concentrations of 
cholesterol enriched diet.     Several medicinal plants 
have been reported to be useful in diabetes worldwide 
and have been used empirically as anti-diabetic and anti-
hyperlipidemic remedies
14
. A survey revealed that a 
number of cyclopeptide and isoquinoline alkaloids, 
flavonoids, terpenoids and their glycosides have been 
found to occur in various amounts in most Ziziphus 
species
15
. Various researches has been done to show the 
anti-diabetic effects Ziziphus species such as,Anti 
diabetic activity of Ziziphus mauritiana in streptozotocin 
induced Diabetic Rats and its comparison with some 
standard flavonoids by 
14
, the comparative 
antihyperglycemic, antihyperlipidemic and antioxidant 
effects of Ziziphus spina christi and Ziziphus jujube in 
alloxan induced diabetic rats by 
16
, while there is the 
need to validate the claims that Ziziphus mauritiana and 
Ziziphus spina christiare potent anti-diabetic agents, 
there is also the need to know which of the Ziziphus 
species has a more potent anti-diabetic effect. As a 
certified anti-diabetic drug, glibenclamide was used in 
this study based on the fact that based it has health 
benefits such as it having a fast onset of action, little to 
no effect on blood pressure and lower risk of 
gastrointestinal problems compared to chlopropamide 
(which was the original drug intended for this study but 
wasn’t used because it has been banned) and other anti-
diabetic drugs such as metformin and miglitol
17
. The aim 
of this research is to compare the anti-diabetic efficacy 
of hydro-methanolic (50:50) of Ziziphus mauritiana 
(HMZM) and Ziziphus spina christi (HMZS) fruit 
extract with antidiabetic drug Glibenclamide. 
MATERIALS AND METHODS             
Collection and Preparation of Plant Material 
Ziziphusmauritiana fruits were obtained dried from Rimi 
market, Kano state, Nigeria. The fruits were 
authenticated and given voucher number 
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DPB/BUK/HIF/0408 at the Plant Biology Department, 
Faculty of Life Sciences, Bayero University Kano, 
Nigeria. The fruit extracts were prepared by crushing the 
mesocarps of Ziziphusmauritiana. The dried mesocarps 
were ground to powder using mortar and pestle. The 
powdered fruit mesocarp was soaked in a mixture of 
water and methanol respectively (50:50) and allowed to 
stay for 48 hours at room temperature after which they 
were filtered.  After filtration, 100ml of the extracts was 
then taken and evaporated to dryness using a rotary 
evaporator at 80
°
C. The evaporated extracts were then 
reconstituted with distilled water relative to the weight 
of the evaporated extracts. 
Experimental Animals 
Policy of Bayero University Kano on research involving 
laboratory animals was followed in this study. Fifty-six 
male albino rats were used in this study. The rats were 
kept in cages under standard conditions and were fed 
with pelletized growers feed. They were allowed to 
acclimatize for a week before commencement of the 
experiment. 
Experimental Design 
A total of twenty-six rats were used for testing the acute 
toxicity of the extract of Ziziphus mauritiana fruit while 
thirty rats were used for testing the antidiabetic effects of 
the extract in comparison with antidiabetic drug, 
glibenclamide. The rats were distributed into five (5) 
groups of six (6) rats each as follows: 
Group 1 – Six (6) non-diabetic rats fed with normal feed 
(Negative control)   
Group 2- Six (6) diabetic rats fed with normal feed 
(Positive control) 
Group 3 - Six (6) diabetic rats administered with 
200mg/kg of the hydro methanolic extract of the fruit of 
Ziziphusmauritiana 
Group 4- Six (6) diabetic rats administered with 
400mg/kg of the hydro methanolic extract of the fruit of 
Ziziphusmauritiana 
Group 5- Six (6) diabetic rats administered with 
0.21mg/kg of glibenclamide  
The blood glucose levels of the rats in all groups were 
determined before commencement of the experiment by 
use of a glucometer. Also, after treatment with alloxan, 
the blood glucose levels were determined to confirm that 
the rats (from groups 2-5) were diabetic, before oral 
administration of extracts and glibenclamide. Blood 
glucose levels were also determined on the 7
th
 day and 
on the 14
th
 day post extract and glibenclamide 
treatments. 
On the 7
th
 and 14
th
 day, the animals were sacrificed 
(three rats per group on each day) by decapitation and 
blood was obtained to determine the blood glucose 
levels, serum protein, serum albumin and lipid profile of 
the rats.  
Induction of Diabetes 
A stock solution was prepared by dissolving 0.4g of 
alloxan monohydrate in 4ml of normal saline. Normal 
saline was prepared by dissolving 0.95g of salt in 100ml 
of distilled water
18
. Diabetes was induced by single 
intraperitoneal injection of alloxan monohydrate. The 
rats in group 2-7 were intraperitoneally administered 
with 360mg/kg of alloxan in normal saline respectively.   
Acute Toxicity Study 
The acute toxicities of the hydro-methanolic fruit 
extracts of Ziziphusmauritiana were evaluated in two 
phases as described by
19
. In the 1
st
 phase doses of 
10mg/kg, 100mg/kg, and 100mg/kg were administered 
to 3 rats each. In the absence of any mortality in the1st 
phase, higher doses of 1500mg/kg, 2500mg/kg, 
3500mg/kg and 5000mg/kg were then administered on 1 
rat each. 
Determination of Biochemical Markers of Diabetes 
Mellitus 
Blood Glucose was determined by the method of 
20
; 
Serum Total Protein was determined by biuret method 
21
; serum total cholesterol was determined using the 
method of 
22
; Serum Level of HDL and LDL-
Cholesterol was carried out using the method of 
23
; 
Serum Triacylglycerol was determined by the method of 
22
. 
Reagents: All reagents used for the analysis of glucose, 
lipid profile and albumin in this study are of analytical 
grade purchased as kits produced by Randox 
Laboratories Limited, United Kingdom. 
Statistical analysis 
The results obtained in all the experiments were 
expressed as mean ± standard deviation. Statistical 
analysis was carried out by using one way ANOVA as in 
standard statistical software package of social science 
and a component of Graph Pad Instat3 Software version 
3.05 by Graph Pad Inc. was used with significant 
difference measured at (P < 0.05)
24
. 
RESULTS AND DISCUSSION 
Results 
Acute Toxicity  
The results of the acute toxicity of hydro-methanolic 
Ziziphusmauritiana(HMZM) extract is shown in table 1. 
In the 1
st
 phase, doses of 10mg/kg, 100mg/kg, and 
1000mg/kg were administered to 3 rats each of which no 
mortality was observed. In the absence of mortality in 
the1st phase, higher doses of 1500mg/kg, 2500mg/kg, 
3500mg/kg and 5000mg/kg were then administered on 1 
rat each of which no mortality was observed in the 2
nd
 
phase of the experiment.  
Table 1a: Acute Toxicity of Phase I hydro-methanolic 
fruit extract of Ziziphusmauritiana 
Doses (mg/kg) Result of First Phase 
10 0/3 
100 0/3 
1000 0/3 
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Table 1b: Phase II hydro -methanolic fruit extract of 
ziziphusmauritiana 
Doses (mg/kg) Result of Second Phase 
1500 0/1 
2500 0/1 
3500 0/1 
5000 0/1 
 
The results of the acute toxicity of hydro-methanolic 
Ziziphusspina christi(HMZS) extract is shown in table 2. 
In the 1
st
 phase, doses of 10mg/kg, 100mg/kg, and 
100mg/kg were administered to 3 rats each of which no 
mortality was observed. In the absence of mortality in 
the1st phase, higher doses of 1500mg/kg, 2500mg/kg, 
3500mg/kg and 5000mg/kg were then administered on 1 
rat each of which no mortality was observed in the 2
nd
 
phase of the experiment. 
Table 2a: Acute Toxicity of phase I hydro-methanolic 
fruit extract of Ziziphus spina christi 
Doses (mg/kg) Result of First Phase (Mortality) 
10 0/3 
100 0/3 
1000 0/3 
 
Table 2b: phase II hydro-methanolic fruit extract of 
Ziziphus spina christi 
Doses (mg/kg) Result of Second Phase (Mortality) 
1500 0/1 
2500 0/1 
3500 0/1 
5000 0/1 
 
The result of the effects of HMZM and HMZS on blood 
glucose in diabetic rats is shown in Figure 1 below. All 
the experimental groups (groups 3, 4, 5 and 6) showed a 
similar pattern of time dependency in blood glucose 
reduction during the 14 days treatment. As at the first 
day of the experiment (immediately after diabetes 
induction) group 1 rats (negative control) had a 
significantly lower (P < 0.05) blood glucose level 
compared to rats in group 2 (positive control), group 3 
(200mg/kg HMZM), group 4 (400mg/kg HMZM), group 
5 (200mg/kg HMZS), group 6 (400mg/kg HMZS), and 
group 7 (0.2143mg/kg of glibenclamide). However, no 
significant differences (P > 0.05) were observed when 
blood glucose levels of rats in groups 2-7 were 
compared at day 1. The significantly higher (P < 0.05) 
level of blood glucose observed in groups 2-7 rats 
compared to group 1 confirms that the rats were 
diabetic. 
The blood glucose levels as at the 7
th
 day of 
administration of HMZM and HMZS shows a 
significantly lower (P < 0.05) level of blood glucose in 
all groups compared to rats in group 2 (table 3). 
Significant differences (P < 0.05) were also observed 
when blood glucose of group 3 and group 4, group 5 and 
group 6 were compared. The groups having the lowest 
blood glucose level were group 1, group 7 and group 6 
(table 3). Significant difference (P < 0.05) was observed 
in the blood glucose levels of all groups (1-7) when 
compared to one another. However, there were no 
significant differences (P > 0.05) observed between rats 
in group 7 and group 6, group 3 and group 5. 
The blood glucose levels as at the 14
th
 day of 
administration of HMZM and HMZS shows a 
significantly lower (P < 0.05) level of blood glucose of 
rats in groups 1, group 3, group 4, group 5, group 6 and 
group 7 compared to rats in group 2 with group 1 and 
group 7 rats having the lowest blood glucose level (table 
3). Significant differences (P < 0.05) were observed 
when serum blood glucose level of rats in groups 3 and 
4, groups 5 and 6 were compared. With the exception of 
group 4 and group 5 of which no significant difference 
(P > 0.05) was observed in their blood glucose levels, 
significant difference (P < 0.05) was observed in the 
blood glucose levels of all groups when compared to one 
another. The decrease in blood glucose level was found 
to be dose dependent such that blood glucose level of 
rats decreased with a corresponding increase in the doses 
of HMZM and HMZS extracts respectively.
 
 
Table 3: Blood Glucose concentrations (mg/dl) determined 48hrs after alloxan diabetes induction, 7
th
 and 14
th
 
day of HMZM and HMZS extracts and glibenclamide administration 
 48hrs After Alloxan 7
th
 day of Administration 14
th
dayof Administration  
GRP I 59.17±10.74
ab
 53.67±14.26
a
 43.67±4.04
b
 
GRP 2 238.00±48.98
a
 241.50±90.64 205.00±4.58
a
 
GRP 3 287.83±111.65
ab
 207.67±30.38
a
 132.33±56.04
b
 
GRP 4 241.83±40.81
ab
 162.50±36.65
a
 78.67±15.01
b
 
GRP 5 299.50±31.82
ab
 191.67±47.38
a
 92.00±17.09
b
 
GRP 6 272.50±120.46
ab
 123.00±27.61
a
 70.67±8.50
b
 
GRP 7 323.50±132.80
ab
 109.00±43.97
a
 54.00±8.72
b
 
Results are mean ± standard deviation, Values in the same row bearing similar superscripts are significantly different at P<0.05. 
(n=6). Key: GRP1: Negative Control, GRP2: positive Control, GRP3: Test group, GRP4: Test group, GRP5: Test group5, GRP6: 
Test group6, GRP7: Test group7 
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Results are expressed as Mean ± Standard Deviation (n=3). 
Letters a, b, c, d, e and f indicates significant difference 
(P < 0.05) when group 2 was compared with groups 1, 
3, 4, 5, 6 and 7, respectively. HMZM- Hydro-
methanolicZiziphusmauritiana; HMZS- Hydro-
methanolicZiziphus spina Christi; GBC- Glibenclamide 
The results of the effects of hydro-methanolic fruit 
extracts of Ziziphusmauritiana and Ziziphus spina 
Christi on cholesterol, High Density Lipoprotein (HDL), 
Low Density Lipoprotein (LDL) and triacylglycerol are 
presented in Figures 2, 3, 4 and 5 respectively. The 
decrease in mean serum level of cholesterol, HDL-C, 
LDL-C and triglycerides was found to be dose 
dependent and it occurred with an increase in the doses 
of hydro methanolic Ziziphusmauritiana and Ziziphus 
spina christiextracts respectively. 
As shown Figure 2, the results obtained on the 7
th
 day of 
administration of HMZM and HMZS show a 
significantly higher (P < 0.05) level of serum 
triglycerides in group 2 rats (positive control), compared 
to rats in group 1 (negative control), group 3 (200mg/kg 
of HMZM), group 4 (400mg/kg of HMZM) group 5 
(200mg/kg of HMZS), group 6 (400mg/kg of HMZS), 
and group 7  (0.2143mg/kg of glibenclamide). 
Significant differences (P < 0.05) were also observed 
when the serum triglyceride level of rats in group 3 and 
group 4, group 5 and group 6, were compared. 
Significant difference (P < 0.05) was observed when the 
serum triacylglycerol levels of all groups (1-7) were 
compared with one another. However, there were no 
significant differences (P > 0.05) in the serum 
triacylglycerol level of group 6 rats compared to group 
7.
 
Results are expressed as Mean ± Standard Deviation (n=3). 
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The results obtained as at the 14
th
 day of administration 
shows a significantly lower (P < 0.05) level of serum 
triacylglycerol of rats in groups 1, 3, 4, 5, 6 and 7 
compared to rats in group 2, Significant differences (P < 
0.05) were also observed when the serum triacylglycerol 
level of rats in groups 3 and 4, 5 and 6, were compared. 
Significant difference (P < 0.05) was observed when the 
serum triacylglycerol levels of all groups (1-7) were 
compared with one another. However, no significant 
differences (P > 0.05) were observed in the serum 
triglyceride levels of group 1, group 6 and group 7 rats 
which were having the lowest serum triacylglycerol 
level. 
Letters a, b, c, d, e and ‘f’ indicates significant 
difference (P < 0.05) when group 2 was compared with 
groups 1, 3, 4, 5, 6 and 7, respectively. HMZM- 
Ziziphusmauritiana(Hydro-methanolic fruit extract); 
HMZS- Ziziphus spina christi(Hydro-methanolic fruit 
extract); GBC- Glibenclamide 
Figure 3, shows the results obtained on the 7
th
 day of 
administration of HMZM and HMZS there was a 
significantly higher (P < 0.05) level of serum HDL in 
group 2 rats (positive control), compared to rats in group 
1 (negative control), group 3 (200mg/kg of HMZM), 
group 4 (400mg/kg of HMZM), group 5 (200mg/kg of 
HMZS), group 6 (400mg/kg of HMZS), and group 7  
(0.2143mg/kg of Glibenclamide). Significant differences 
(P < 0.05) were also observed when the serum HDL 
level of rats in groups 3 and 4, 5 and 6, were compared. 
Significant difference (P < 0.05) was observed when the 
serum HDL-Cholesterol levels of all groups (1-7) were 
compared with one another. There was no significant 
difference (P > 0.05) in the serum HDL level of group 4 
compared to group 6. 
The results obtained on the 14
th
 day of administration 
show further regression in the serum HDL of rats in 
groups 1, 3, 4, 5, 6 and 7 compared to rats in group 
2.Significant differences (P < 0.05) were also observed 
when the serum HDL level of rats in groups 3 and 4, 5 
and 6, were compared. Significant difference (P < 0.05) 
was observed when the serum HDL-Cholesterol levels 
of all groups (1-7) were compared with one another. 
However, no significant difference (P > 0.05) was 
observed when the serum HDL-Cholesterol level of 
groups 1, 4 and 7 rats were compared. 
 
 
Results are expressed as Mean ± Standard Deviation (n=3); Letters a, b, c, d, e and ‘f’ indicates significant difference (P < 0.05) 
when group 2 was compared with groups 1, 3, 4, 5, 6 and 7, respectively; HMZM- Ziziphusmauritiana(Hydro-methanolic fruit 
extract); HMZS- Ziziphus spina christi(Hydro-methanolic fruit extract); GBC- Glibenclamide. 
 
Figure 4, shows the results obtained on the 7
th
 day of 
administration of HMZM and HMZS there was a 
significantly higher (P < 0.05) level of serum cholesterol 
in group 2 rats (positive control), compared to rats in 
group 1 (negative control), group 3 (200mg/kg of 
HMZM), group 4 (400mg/kg of HMZM), group 5 
(200mg/kg of HMZS), group 6 (400mg/kg of HMZS), 
and group 7  (0.2143mg/kg of Glibenclamide). 
Significant differences (P < 0.05) were also observed 
when the serum Cholesterol level of rats in group 3 and 
group 4, group 5 and group 6, were compared. 
Significant difference (P < 0.05) was observed when the 
serum Cholesterol levels of all groups (1-7) were 
compared with one another. However, there was no 
significant difference (P > 0.05) in the serum cholesterol 
level of group 6 compared to group 7. 
The results obtained as at the 14
th
 day of administration 
showed further regression in the serum cholesterol of 
rats in groups 1, 3, 4, 5, 6 and 7 compared to rats in 
group 2. Significant differences (P < 0.05) were also 
observed when the serum Cholesterol level of rats in 
groups 3 and 4, 5 and 6, were compared. Significant 
difference (P < 0.05) was observed when the serum 
Cholesterol levels of all groups (1-7) were compared 
with one another. However no significant differences (P 
> 0.05) was observed when the serum cholesterol level 
of group 1 compared groups 6 and 7 rats, and 4 
compared to group 5 rats. 
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Results are expressed as Mean ± Standard Deviation (n=3); Letters a, b, c, d, e and ‘f’ indicates significant difference (P < 0.05) 
when group 2 was compared with groups 1, 3, 4, 5, 6 and 7, respectively; HMZM- Ziziphusmauritiana(Hydro-methanolic fruit 
extract); HMZS- Ziziphus spina christi(Hydro-methanolic fruit extract); GBC- Glibenclamide 
 
Figure 5, shows the results obtained on the 7
th
 day of 
administration of HMZM and HMZS there was a 
significantly higher (P < 0.05) level of serum LDL in 
group 2 rats (positive control), compared to rats in group 
1 (negative control), group 3 (200mg/kg of HMZM), 
group 4 (400mg/kg of HMZM), group 5 (200mg/kg of 
HMZS), group 6 (400mg/kg of HMZS), and group 7 
(0.2143mg/kg of glibenclamide).Significant differences 
(P < 0.05) were also observed when the serum LDL-
Cholesterol level of rats in groups 3 and 4, 5 and 6, were 
compared. Significant difference (P < 0.05) was 
observed when the serum LDL-Cholesterol levels of all 
groups (1-7) were compared with one another. There 
were no significant differences (P > 0.05) observed in 
the serum LDL level of group 4 compared to groups 5 
and 6 compared to group 7. 
The results obtained as at the 14
th
 day of administration 
shows further regression in the serum LDL-Cholesterol 
of rats in groups 1, 3, 4, 5, 6 and 7 compared to rats in 
group 2.Significant differences (P < 0.05) were also 
observed when the serum LDL level of rats in group 3 
and 4, 5 and 6, were compared. Significant difference (P 
< 0.05) was observed when the serum LDL-Cholesterol 
levels of all groups (1-7) were compared with one 
another. However no significant difference (P > 0.05) 
was observed when the serum LDL levels of groups 1 
and 7 rats were compared. 
 
 
Results are expressed as Mean ± Standard Deviation (n=3); Letters a, b, c, d, and e indicates significant difference (P < 0.05) when 
group 2 was compared with groups 1, 3, 4, 5, 6 and 7, respectively; HMZM- Ziziphusmauritiana(Hydro-methanolic fruit extract); 
HMZS- Ziziphus spina christi(Hydro-methanolic fruit extract); GBC- Glibenclamide 
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The results of the effects of hydro-methanolic fruit 
extracts of Ziziphusmauritiana and Ziziphus spina 
christion on total protein and albumin at the 7
th
 and 14
th
 
day are presented in Figures 6 and 7 respectively. The 
increase in the mean serum level of total protein and 
albumin was found to be dose dependent and it occurred 
with an increase in the doses of hydro methanolic 
Ziziphusmauritiana and Ziziphus spina christiextracts 
respectively. 
As shown in Figure 4.6, the results obtained on the 7
th
 
day of administration of HMZM and HMZS show a 
significantly lower (P < 0.05) level of serum total 
protein in group 2 rats (positive control), compared to 
rats in group 1 (negative control), group 3 (200mg/kg of 
HMZM), group 4 (400mg/kg of HMZM), group 5 
(200mg/kg of HMZS), group 6 (400mg/kg of HMZS), 
and group 7 (0.2143mg/kg of glibenclamide).Significant 
differences (P < 0.05) were also observed when the 
serum total protein level of rats in groups 3 and 4, 5 and 
6, were compared. Significant difference (P < 0.05) was 
observed when the serum total protein levels of all 
groups (1-7) were compared with one another. However, 
there was no significant difference (P > 0.05) in the 
serum total protein level of group 4 compared to groups 
5, 6 and 7. 
The results obtained as at the 14
th
 day of administration 
shows increase in the serum total protein of rats in 
groups 1, 3, 4, 5, 6 and 7 compared to rats in group 
2.Significant differences (P < 0.05) were also observed 
when the serum total protein level of rats in groups 3 and 
4, 5 and 6, were compared. Significant difference (P < 
0.05) was observed when the serum total protein levels 
of all groups (1-7) were compared with one another 
however no significant difference (P > 0.05) was 
observed when the serum total protein level of groups 1 
and 7 rats were compared. 
 
 
Results are expressed as Mean ± Standard Deviation (n=3); Letters a, b, c, d, and e indicates significant difference (P < 0.05) when 
group 2 was compared with groups 1, 3, 4, 5, 6 and 7, respectively; HMZM- Ziziphusmauritiana(Hydro-methanolic fruit extract); 
HMZS- Ziziphus spina christi(Hydro-methanolic fruit extract); GBC- Glibenclamide 
 
Figure 7, shows the results obtained on the 7
th
 day of 
administration of HMZM and HMZS there was a 
significantly lower (P < 0.05) level of serum albumin in 
group 2 rats (positive control) (1.26g/dl ± 0.19), 
compared to rats in group 1 (negative control), group 3 
(200mg/kg of HMZM), group 4 (400mg/kg of HMZM), 
group 5 (200mg/kg of HMZS), group 6 (400mg/kg of 
HMZS), and group 7 (0.2143mg/kg of glibenclamide). 
Significant differences (P < 0.05) were also observed 
when the serum albumin level of rats in group 3 and 
group 4, group 5 and group 6, were compared. 
Significant difference (P < 0.05) was observed when the 
serum albumin levels of all groups (1-7) were compared 
with one another. However, there was no significant 
difference (P > 0.05) when the serum albumin level of 
group 7 and group 5 rats, group 1 and group 6 rats, 
group 3 and group 4 rats were compared 
The results obtained as at the 14
th
 day of administration 
shows increase in the serum albumin of rats in group 1, 
group 3, group 4, group 5, group 6 and group 7 
compared to rats in group 2. Significant differences (P < 
0.05) were also observed when the serum albumin level 
of rats in group 3 and group 4, group 5 and group 6, 
were compared. Significant difference (P < 0.05) was 
observed when the serum albumin levels of all groups 
(1-7) were compared with one another.However no 
significant difference (P > 0.05) was observed when the 
serum albumin level of group 3 and group 7 rats, group 
4 and group 5 rats were compared. 
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Results are expressed as Mean ± Standard Deviation (n=3); Letters a, b, c, d, and e indicates significant difference (P < 0.05) when 
group 2 was compared with groups 1, 3, 4, 5, 6 and 7, respectively; HMZM- Ziziphusmauritiana(Hydro-methanolic fruit extract); 
HMZS- Ziziphus spina christi(Hydro-methanolic fruit extract); GBC- Glibenclamide 
 
DISCUSSION 
From the result of acute toxicity study (table 1 and 2) of 
Ziziphusmauritiana and Ziziphus spina Christi, no 
mortality was recorded in any of the experimental 
groups after oral administration of 5000mg/kg of each 
extract, which proves these species harmless and non 
toxic and therefore safe to use. According to toxicity 
classification of 
25
, any compound with oral LD50 of 
5000mg/kg or more should be considered as practically 
harmless. It has been argued that even if LD50 values 
could be measured  exactly and reproducibly, the 
knowledge of its precise numerical value would barely 
be of practical importance, because an extrapolation 
from the experimental animals to man is hardly 
possible
19
. However, it serves a great purpose as a first 
pointer to the safety or toxic potential of a substance 
whose toxicity profile is not yet known. 
Diabetes mellitus is a chronic disease characterized by 
high blood glucose level due to absolute or relative 
deficiency of circulating insulin level or insulin 
resistance. Though there are various types of 
hypoglycemic agent for treatment of diabetes, diabetic 
patients tend to consume natural products with 
antidiabetic activity to overcome side effects and 
toxicity of chemical drugs. Herbal antidiabetic drugs are 
used because they are effective and have low cost and 
less side effects
26
.  The data (figure 1) obtained in this 
study with regards to the control values are in some 
ways similar to a study carried out by
16
 who studied the 
Antihyperglycemic, antihyperlipidemic  and  antioxidant  
effects of Ziziphus spina christi and  Ziziphus jujube in 
alloxan induced diabetic rats with differences mainly in 
the lipid profile. The significantly higher (P < 0.05) 
mean serum level of glucose in the diabetic control rats 
when compared to normal control rats may be due to 
possible damage to the pancreatic β- islet cells by the 
effect of alloxan. Alloxan selectively destroys the islets 
of langerhans and decreases insulin production which 
results in diabetes
27
. Also, alloxan increases free radical 
production and cause pancreatic injury
18
. In otherwise, 
glibenclamide exerts hypoglycemic action by 
stimulation insulin secretion and inhibition of glucagon 
release. Previous studies carried out by
28
 on the 
phytochemistry of various Ziziphus species have shown 
that HMZM and HMZS contain saponins, tannins, 
carbohydrates and flavonoids. Thus, the regression in 
blood glucose level may be attributed to the presence of 
phytochemicals such as saponins and tannins which 
reduce blood glucose level by increasing insulin levels 
due to the stimulating effect of the extracts on the 
remaining β cells in the pancreas after alloxan injection. 
The tannins in Ziziphus fruits have antioxidative effect. 
Oxidative stress is one of the important factors in tissue 
injury in diabetes mellitus
29
. These potent antioxidants 
may protect beta cells and increase insulin secretion in 
diabetic patients. Also, tannins may inhibit insulin 
degradation and improve glucose utilization by 
stimulation of GLUT4 (Glucose Transporter 4) protein 
content of the muscle
30
. 
The significantly lower (P < 0.05) mean serum level of 
glucose as observed in the glibenclamide treated rats in 
comparison to Group 2 rats could be due to the fact that 
glibenclamide exerts its hypoglycemic effect by binding 
to and inhibiting the ATP sensitive potassium channels 
(KATP) inhibitory regulatory subunit sulfonylurea 
receptor 1 (SUR1) in pancreatic beta cells. This 
inhibition causes cell membrane depolarization, opening 
voltage dependent calcium ion channels resulting in an 
increase in intracellular calcium in the beta cell and 
subsequent stimulation of insulin release
31
.  Hence it can 
be inferred that both HMZM and HMZS can be used as 
safe potential natural functional food ingredient or 
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therapeutic drug in the treatment of diabetes. In addition, 
they are effective in reducing both hyperglycemia and 
oxidative stress accompanying diabetes
16
 and although 
glibenclamide exerted more hypoglycemic and 
hypolipidemic effects compared to HMZM and HMZS, 
Ziziphus spina christiextract has more pronounced 
effects than Ziziphusmauritiana. 
The significantly higher (P < 0.05) serum lipids level 
observed in the groups 2-7 rats might be as a result of 
disturbance in the regulation of the activity of the 
enzyme, hormone sensitive lipase, by insulin due to its 
deficiency or absence, caused by the alloxan induced 
destruction of β- islet cells31. Insulin deficiency in 
diabetes induces the   synthesis of lipase which 
enhances lipolysis and increases the concentration of 
free fatty acids in plasma and liver. Glucagon level also 
increases in diabetes which enhances the release of 
fatty acids. Excess fatty acids in serum promote their 
conversion into cholesterol and TG with concomitant 
increase in LDL
32
. Moreover, insulin deficiency   
elevates LDL level and consequently the levels of 
cholesterol
33
.  
Several researchers have reported the use of plant fruits 
in reducing LDL TC and TG, exerting their lipid 
lowering effects
34
. The decrease in mean serum level of 
cholesterol, Low Density Lipoprotein (LDL) and 
triacylglycerol (TG) in this study, tend to support the 
claim of the use of plant fruits in the management of 
hypolipideamia resulting from diabetes. However, this 
may also be due to the presence of saponins which were 
also reported to have hypolipidemic effects by reducing 
total cholesterol, triglycerides, HDL and LDL 
cholesterol. This could be due to the fact that saponins 
form an insoluble complex with cholesterol, increase 
fecal lipid excretion
35
. They also increase liver LDL 
receptor activity and also decrease synthesis of 
triglycerides
36
. The obtained results are also in 
agreement with
37
 that proved the antidiabetic effect of 
some Ziziphus species.  
Hence it can be inferred that both hydro-methanolic fruit 
extracts of Ziziphusmauritiana and Ziziphus spina 
Christi are effective in reducing hyperlipidemia 
accompanying diabetes. However, Ziziphus spina Christi 
fruit extract has more pronounced effects than 
Ziziphusmauritiana. 
The significantly lower (P < 0.05) serum total protein 
level observed in the diabetic control rats might be as a 
result of increased breakdown of protein to generate 
ketogenic amino acids via gluconeogenesis for energy 
production. With insulin deficiency, the oxidation of 
branched chain amino acids in muscle and uptake of 
alanine by the liver are accelerated, resulting in 
increased gluconeogenesis and augmented protein 
catabolism
38
. The results of the present study 
demonstrated that the treatment of diabetic rats with 
hydro-methanolic extracts of Ziziphusmauritiana and 
Ziziphus spina christi resulted to a noticeable elevation 
in the plasma total protein and albumin levels as 
compared with their normal levels. It has been 
established that insulin stimulates the incorporation of 
amino acids into proteins
33
. 
CONCLUSION 
In conclusion, this study has revealed that HMZM and 
HMZS could be used as safe potential natural 
functional food ingredient or therapeutic drug in the 
treatment of diabetes. In addition, they are effective in 
reducing both hyperlipidemia and hypoglycemia 
accompanying diabetes. Although the most effective 
dose which was 400mg/kg of Ziziphus spina Christi 
extract had more pronounced antidiabetic effects than 
Ziziphusmauritiana, it was found to be less than that 
produced by the reference drug (glibenclamide). Hence 
it can be inferred that both hydro-methanolic fruit 
extracts of Ziziphusmauritiana and Ziziphus spina 
christican can be used as therapeutic drug in the 
treatment of diabetes. 
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